-
HIV Drug Resistance Is Declining Over Time
24 Sep 2025 20:12 GMT
… DNA.” When antiretroviral medications are used incorrectly … drugs, reducing their effectiveness and compromising future treatment … pills containing tenofovir disoproxil fumarate (including Truvada and Atripla … the Delstrigo combination pill) was 2% in …
-
Generic competition and pricing practices continue to spearhead rise in US pharmaceutical antitrust cases
11 Aug 2025 14:06 GMT
… trials both concerned the same product, Opana. The first Opana trial … from older HIV treatments to newer treatments.[105] But … to eliminate the ‘pill penalty’, stating that it ‘threatens … requires pharmaceutical manufacturers to provide outpatient drugs at …
-
A Student Pharmacist’s Guide to HIV Medications
23 May 2025 17:23 GMT
… -based regimens. These drug combinations include Odefsey ( … tenofovir disoproxil fumarate), and Atripla (efavirenz/emtricitabine… if combined with statin medications such as lovastatin … hiv-treatment-regimen
4. HIV treatment: FDA-approved HIV medicines. …
-
Gilead Sciences Announces Fourth Quarter and Full Year 2025 Financial Results
10 Feb 2026 22:51 GMT
… HIV prevention and treatment.
Biktarvy® (bictegravir … and additional clinical trials, including those … SCIENCES®, KITE®, AMBISOME®, ATRIPLA®, BIKTARVY®, CAYSTON®, COMPLERA®, … INFECTIOUS DISEASES HOSPITALS PHARMACEUTICAL BIOTECHNOLOGY
SOURCE: Gilead Sciences …
-
HIV Drugs Market Outlook: Future Trends Indicate a US$ 47.5 Billion Industry by 2034 with a Shift Toward Single-dose Regimens | Report by TMR
18 Mar 2025 11:28 GMT
… trials for its next-generation HIV treatment targeting drug- … to PrEP and ART medications.
Government & NGO … Biktarvy, Truvada, Descovy, Atripla
Expansion in long-acting therapies … on affordable HIV treatment
Teva Pharmaceutical Industries Ltd.
Generic …
-
HIV Treatment Information for Pregnant Women
30 Jan 2025 20:04 GMT
Atripla*
efavirenz 600 mg
emtricitabine 200 … Oral Tablet
Embryo-Fetal Toxicity
Atripla Label
Biktarvy*
bictegravir 50 mg … information available for the approved treatment dose of 600 mg twice … information available for the approved treatment dose of 600 mg …
-
3 Biotechnology Stocks With Promising Pipelines
02 Nov 2024 00:15 GMT
… strong biotech stocks Amgen Inc. (AMGN), Regeneron Pharmaceuticals, Inc … personalized medicine, and rapid acceleration in drug discovery … phase 3 PHOTON trial continued to demonstrate … FDA approval for Dupixent® (dupilumab) as an add-on maintenance treatment …
-
27 Individuals Indicted for Buying and Selling Wholesale Quantities of Misbranded and Diverted Prescription Drugs Resold to the Public Through Retail Pharmacies in Puerto Rico
27 Sep 2024 16:15 GMT
… through licensed pharmaceutical distribution channels. By selling diverted prescription drugs and … Ellipta, Arnuity Ellipta, Aspen Dexamfetamine, Atripla, Atrovent, Azopt, Bepreve, Biktarvy, … on the FDA website. If someone is having a medical emergency, …
-
January - March 2019 | Potential Signals of Serious Risks/New Safety Information Identified from the FDA Adverse Event Reporting System (FAERS)
16 Sep 2024 17:01 GMT
… -acting antiviral drugs for the treatment of chronic … labeling, and the “Medication Guide” were updated …
Zepatier labeling
An FDA Drug Safety Communication for … lamivudine, tenofovir disoproxil fumarate)
Atripla (efavirenz, emtricitabine, tenofovir …
-
FTC v Actavis and pricing practices spearhead rise in US pharmaceutical antitrust cases
12 Aug 2024 10:51 GMT
… trials both concerned the same product, Opana. The first Opana trial … from older HIV treatments to newer treatments.[93] But … allegations that the Medicare Drug Price Negotiation programme … requires pharmaceutical manufacturers to provide outpatient drugs at …
About
© 1995-2026